tadalafil has been researched along with Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, WJ; Cheng, HJ; Huang, YP; Li, L; Lu, MJ; Peng, Y; Wu, ZM; Yang, NQ | 1 |
| Deibert, P; Kreisel, W; Lazaro, A; Rössle, M; Schaffner, D; Stankovic, Z | 1 |
| Cho, DY; Kim, JJ; Kim, JW; Moon, du G; Oh, MM; Park, MG; Yeo, JK | 1 |
| Chatterjee, S; Russell, A; Seed, M | 1 |
| Bischoff, E; Huetter, J; Neuser, D; Sandner, P; Stelte-Ludwig, B; Tinel, H; Ulbrich, E | 1 |
2 trial(s) available for tadalafil and Syndrome
| Article | Year |
|---|---|
The efficacy of combination treatment with injectable testosterone undecanoate and daily tadalafil for erectile dysfunction with testosterone deficiency syndrome.
Topics: Adult; Aged; Carbolines; Delayed-Action Preparations; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Syndrome; Tadalafil; Testosterone | 2015 |
[PDE5 inhibitors in treatment of benign prostatic syndrome].
Topics: Animals; Carbolines; Cell Division; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Imidazoles; Isometric Contraction; Male; Middle Aged; Muscle, Smooth; Organ Culture Techniques; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Prostate; Prostatic Hyperplasia; Purines; Rats; Sildenafil Citrate; Stromal Cells; Sulfones; Syndrome; Tadalafil; Triazines; Urethra; Urinary Bladder; Vardenafil Dihydrochloride | 2007 |
3 other study(ies) available for tadalafil and Syndrome
| Article | Year |
|---|---|
[Effect of Shanhaidan Granules combined with tadalafil on erectile dysfunction: A multi-center clinical trial].
Topics: Erectile Dysfunction; Humans; Male; Medicine, Chinese Traditional; Penile Erection; Syndrome; Tadalafil | 2021 |
Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up.
Topics: Administration, Oral; Cholangitis, Sclerosing; Computed Tomography Angiography; Endoscopy, Digestive System; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Liver Cirrhosis; Middle Aged; Phosphodiesterase 5 Inhibitors; Syndrome; Tadalafil; Time Factors; Treatment Outcome; Vardenafil Dihydrochloride | 2018 |
Does this case hold the answer to one of the worse types of pain in medicine--that of loin pain haematuria syndrome (LPHS).
Topics: Adult; Analgesics, Opioid; Drug Administration Schedule; Female; Hematuria; Humans; Pain, Intractable; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Ramipril; Recurrence; Syndrome; Tadalafil; Treatment Outcome; Ureter | 2015 |